Literature DB >> 22239215

Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.

Diarmaid O'Donghaile, Walter Kelley, Harvey G Klein, Willy A Flegel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239215      PMCID: PMC3261523          DOI: 10.1111/j.1537-2995.2011.03465.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

1.  Determinants of ABH expression on human blood platelets.

Authors:  Laura L W Cooling; Kathleen Kelly; James Barton; Debbie Hwang; Theodore A W Koerner; John D Olson
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

2.  Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.

Authors:  Friedgard Julmy; Roland A Ammann; Behrouz Mansouri Taleghani; Stefano Fontana; Andreas Hirt; Kurt Leibundgut
Journal:  Transfusion       Date:  2008-09-04       Impact factor: 3.157

3.  How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?

Authors:  Jennifer Daniel-Johnson; Joseph Schwartz
Journal:  Transfusion       Date:  2011-03-07       Impact factor: 3.157

4.  A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.

Authors:  Karen Quillen; Sherry L Sheldon; Jennifer A Daniel-Johnson; A Hallie Lee-Stroka; Willy A Flegel
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

5.  ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation.

Authors:  T Matsui; T Shimoyama; M Matsumoto; Y Fujimura; Y Takemoto; M Sako; J Hamako; K Titani
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

  5 in total
  13 in total

1.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012.

Authors:  Willy A Flegel; Susan T Johnson; Margaret A Keller; Ellen B Klapper; Hanh M Khuu; Joann M Moulds; Axel W Seltsam; Gary Stack; Maryse St-Louis; Christopher A Tormey; Franz F Wagner; Christof Weinstock; Mark H Yazer; Gregory A Denomme
Journal:  Blood Transfus       Date:  2013-10-18       Impact factor: 3.443

2.  How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation.

Authors:  Elizabeth S Allen; Randin C Nelson; Willy A Flegel
Journal:  Transfusion       Date:  2018-09-28       Impact factor: 3.157

Review 3.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

4.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.

Authors:  Willy A Flegel; Lilian Castilho; Meghan Delaney; Ellen B Klapper; Joann M Moulds; France Noizat-Pirenne; Nadine Shehata; Gary Stack; Christopher A Tormey; Franz F Wagner; Dan A Waxman; Christof Weinstock; Silvano Wendel; Gregory A Denomme
Journal:  Blood Transfus       Date:  2014-12-02       Impact factor: 3.443

5.  ABO genotyping: the quest for clinical applications.

Authors:  Willy A Flegel
Journal:  Blood Transfus       Date:  2012-11-27       Impact factor: 3.443

Review 6.  Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.

Authors:  Joan Cid; Miguel Lozano; Harvey G Klein; Willy A Flegel
Journal:  Blood Transfus       Date:  2014-03-19       Impact factor: 3.443

Review 7.  Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Authors:  Patricia M Kopko
Journal:  Transfus Med Hemother       Date:  2015-10-29       Impact factor: 3.747

Review 8.  [When A is not A anymore: problems and pitfalls with blood group typing].

Authors:  P Möhnle; A Humpe; G Wittmann
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

9.  The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.

Authors:  Lisa K Vande Vusse; David K Madtes; Katherine A Guthrie; Terry B Gernsheimer; J Randall Curtis; Timothy R Watkins
Journal:  Transfusion       Date:  2013-08-27       Impact factor: 3.157

10.  ABO chimerism determined by real-time polymerase chain reaction analysis after ABO-incompatible haematopoietic stem cell transplantation.

Authors:  Feng Liu; Guining Li; Xiaolu Mao; Lihua Hu
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.